Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Enact Holdings, Inc. (Nasdaq: ACT) SEC filings, offering a detailed view of how the U.S. private mortgage insurance provider reports its financial condition, capital structure and material events. As a public company headquartered in Raleigh, North Carolina and operating through Enact Mortgage Insurance Corporation, Enact uses its filings to disclose information that is central to understanding its mortgage insurance business.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Enact’s discussion of primary insurance in-force, new insurance written, loss experience, capital sufficiency relative to Private Mortgage Insurer Eligibility Requirements, and the impact of reinsurance and credit facilities. Current reports on Form 8-K supplement these periodic filings by describing specific events, such as the announcement of quarterly financial results or the entry into a senior unsecured revolving credit facility.
Enact’s filings also include details on its credit risk transfer activities, including quota share and excess of loss reinsurance agreements with panels of highly rated reinsurers. These documents explain how portions of expected new insurance written for future book years are covered and how such arrangements affect risk and capital management. The credit agreement filed as an exhibit to an 8-K outlines the terms of the revolving credit facility, including financial covenants tied to consolidated net worth, debt-to-total capitalization and PMIERs compliance.
On Stock Titan, SEC documents for ACT are updated in near real time as they are posted to the EDGAR system. AI-powered summaries help interpret complex sections of 10-Ks, 10-Qs and 8-Ks by highlighting key points about earnings, capital, reinsurance structures and covenants. Users can also review insider and executive transaction reports on Form 4, along with proxy and governance filings, with AI-generated explanations that clarify how these disclosures relate to Enact’s mortgage insurance operations and its relationship with majority owner Genworth Financial, Inc.
Enact Holdings, Inc. reported an insider equity award for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units tied to Enact common stock. These units were credited at a price of $0 per unit under the director award agreement from a cash dividend paid at $0.21 per share on the same date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units, which become payable in shares of common stock one year after the director’s termination of service.
Enact Holdings, Inc. reported that a director and chairperson of the board acquired additional deferred stock units linked to its common stock. On 12/11/2025, 289 deferred stock units were acquired at a price of $0.00 per unit under reinvestment terms tied to a dividend paid on that date at $0.21 per share.
After this transaction, the reporting person beneficially owns 9,012.163 deferred stock units directly. Additional deferred stock units are held indirectly, including 24,177 units through the Deborah Addesso Exempt Irrevocable Trust f/b/o Dominic dated December 28, 2021 and 20,650 units through D.J. Addesso Holdings, LLC. These deferred stock units become payable in shares of common stock one year after termination of service as a director.
Enact Holdings, Inc. disclosed that an officer serving as EVP, CFO and Treasurer acquired additional restricted stock units on December 11, 2025 through dividend reinvestment features in existing awards. On that date, the officer received 38, 67 and 81 restricted stock units at a price of $0.00 each, tied to a quarterly dividend of $0.21 per share paid on December 11, 2025.
Each restricted stock unit will settle into one share of Enact common stock. The related awards vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026. Following these transactions, the officer beneficially owned 7,095, 12,512 and 15,196 restricted stock units across the respective grants.
Enact Holdings, Inc. reported an insider equity transaction by its EVP, General Counsel & Secretary. On December 11, 2025, the executive acquired additional restricted stock units (RSUs) in three separate awards of 17, 27, and 33 units, all at a price of $0 per unit.
Each RSU will settle into one share of Enact common stock. The filing explains that these extra RSUs were credited under the award agreements’ reinvestment terms based on a quarterly dividend of $0.21 per share paid on December 11, 2025. The related RSU awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025, and February 21, 2026, and the executive now directly holds 3,170, 5,006, and 6,080 RSUs under these grants.
Enact Holdings, Inc. reported an insider equity transaction involving deferred stock units for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units linked to Enact common stock.
The award arose from dividend reinvestment under the director award agreement, based on a dividend of $0.21 per share paid on that date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units.
Enact Holdings, Inc. reported an insider transaction by a director involving deferred stock units linked to company dividends. On 12/11/2025, the director acquired 165 deferred stock units under a director award agreement through reinvestment of a cash dividend paid at $0.21 per share.
Following this transaction, the director beneficially owns a total of 30,543.457 deferred stock units on a direct basis. These deferred stock units become payable in shares of Enact Holdings common stock one year after the director’s service on the board ends.
Enact Holdings, Inc. (ACT)11/18/2025, the director sold 2,562 shares of common stock at a weighted average price of $37.411 per share as part of a series of broker-assisted sales ranging from $37.39 to $37.44 per share. On 11/19/2025, the director sold an additional 7,438 shares at $37.39 per share. After these sales, the director reported owning 5,000 shares of Enact common stock directly.
Enact Holdings, Inc. reported Q3 results reflecting steady revenue with softer earnings. Total revenues were $311.5 million versus $309.6 million a year ago, while net income was $163.5 million versus $180.7 million. Diluted EPS was $1.10 compared with $1.15. Net investment income rose to $68.6 million, offset by higher losses incurred of $35.9 million versus $12.2 million.
The balance sheet strengthened as equity reached $5.32 billion and accumulated other comprehensive income improved to $(41.8) million from $(207.5) million at year-end, helped by unrealized gains in the portfolio. Year-to-date, operating cash flow was $538.3 million. Capital returns continued with $105.4 million in share repurchases and $31.0 million in dividends during Q3. The company ended the quarter with $543.6 million in cash and cash equivalents and $744.1 million in long-term borrowings. As of November 3, 2025, common shares outstanding were 144,395,767.
Enact also added protection through reinsurance, including excess-of-loss coverage providing approximately $260 million for policies written in 2026 and $170 million for 2027.
Enact Holdings, Inc. filed a Form 8-K to furnish materials related to its financial results for the quarter ended September 30, 2025. The company provided a press release and a detailed financial supplement to accompany the results.
The information is furnished under Item 2.02 and is not deemed “filed” under Section 18 of the Exchange Act. Exhibits include 99.1 (press release dated November 5, 2025), 99.2 (financial supplement for the quarter), and 104 (cover page Inline XBRL).
Genworth Holdings, Inc. reported the sale of 940,819 shares of Enact Holdings, Inc. common stock on 10/31/2025 at $36.1934 per share. The transaction was effected pursuant to a Share Repurchase Agreement dated April 30, 2025.
Following the sale, Genworth beneficially owns 117,010,462 Enact shares and is identified as a Director and 10% Owner. The filing notes Genworth owns approximately 81% of Enact’s outstanding common stock.